TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive NCAB Plans Study Of Its Authorities. FDA, NIH To Provide $6.75 Million For Grants In Regulatory Science February 26, 2010